{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:14:42Z","timestamp":1788966882229,"version":"build-2803163510"},"reference-count":47,"publisher":"Journal of Rehabilitation Research & Development","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rehabil Res Dev"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1682\/jrrd.2013.04.0092","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T17:27:21Z","timestamp":1398101241000},"page":"81-100","source":"Crossref","is-referenced-by-count":25,"title":["Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA)"],"prefix":"10.1682","volume":"51","author":[{"given":"Dawn","family":"Konrad-Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Reavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garnett","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Helt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Dille","sequence":"additional","affiliation":[{"name":"National Center for Rehabilitative Auditory Research, Portland Department of Veterans Affairs Medical Center, Portland, OR; Departments ofOtolaryngology\/HNS, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"737","reference":[{"issue":"7","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3766\/jaaa.23.7.3","article-title":"Development and validation of a cisplatin dose-ototoxicity model","volume":"23","author":"Dille","year":"2012","journal-title":"J Am Acad Audiol"},{"issue":"3","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1121\/1.3473693","article-title":"Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model","volume":"128","author":"Dille","year":"2010","journal-title":"J Acoust Soc Am"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","article-title":"Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss","volume":"29","author":"Reavis","year":"2008","journal-title":"Ear Hear"},{"issue":"8","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0040-1715935","article-title":"Early detection of ototoxicity using 1\/6th-octave steps","volume":"14","author":"Fausti","year":"2003","journal-title":"J Am Acad Audiol"},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3766\/jaaa.21.5.3","article-title":"Evaluation of audiometric threshold shift criteria for ototoxicity monitoring","volume":"21","author":"Konrad-Martin","year":"2010","journal-title":"J Am Acad Audiol"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1200\/JCO.2003.02.075","article-title":"Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group\/Medical Research Council Testicular Cancer Study Group (30941\/TE20)","volume":"21","author":"Foss\u00e5","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/geront\/43.5.661","article-title":"The impact of hearing loss on quality of life in older adults","volume":"43","author":"Dalton","year":"2003","journal-title":"Gerontologist"},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1590\/S1808-86942009000500004","article-title":"Report on hearing loss in oncology","volume":"75","author":"Schultz","year":"2009","journal-title":"Braz J Otorhinolaryngol"},{"issue":"4 Pt 2","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1288\/00005537-199304000-00001","article-title":"Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents","volume":"103","author":"Schweitzer","year":"1993","journal-title":"Laryngoscope"},{"issue":"4","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/0019-509X.55551","article-title":"Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen","volume":"46","author":"Arora","year":"2009","journal-title":"Indian J Cancer"},{"issue":"7","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/000164800750061624","article-title":"Blood-perilymph barrier and ototoxicity: An in vivo study in the rat","volume":"120","author":"Laurell","year":"2000","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jnci\/djn418","article-title":"Cisplatin and oxaliplatin toxicity: Importance of cochlear kinetics as a determinant for ototoxicity","volume":"101","author":"Hellberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2217\/pgs.11.48","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity","volume":"12","author":"Mukherjea","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.tpj.6500455","article-title":"Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin","volume":"8","author":"Riedemann","year":"2008","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1097\/00005537-200306000-00015","article-title":"A novel model for rapid induction of apoptosis in spiral ganglions of mice","volume":"113","author":"Lee","year":"2003","journal-title":"Laryngoscope"},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MOO.0b013e3282eee452","article-title":"Mechanisms of cisplatin ototoxicity and progress in otoprotection","volume":"15","author":"Rybak","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"7","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1682\/JRRD.2012.09.0176","article-title":"OtoID: New extended frequency, portable audiometer for ototoxicity monitoring","volume":"50","author":"Dille","year":"2013","journal-title":"J Rehabil Res Dev"},{"issue":"11","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r18","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1109\/TBME.2012.2204881","article-title":"Development and evaluation of a portable audiometer for high-frequency screening of hearing loss from ototoxicity in homes\/clinics","volume":"59","author":"Jacobs","year":"2012","journal-title":"IEEE Trans Biomed Eng"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","article-title":"An individualized, sensitive frequency range for early detection of ototoxicity","volume":"20","author":"Fausti","year":"1999","journal-title":"Ear Hear"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r20","unstructured":"American Speech-Language-Hearing Association. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy [Internet]. Rockville (MD): ASHA; 2013. Available from: http:\/\/www.asha.org\/policy\/GL1994-00003.htm"},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r21","first-page":"567","article-title":"An efficient test protocol for identification of a limited, sensitive frequency test range for early detection of ototoxicity","volume":"39","author":"Vaughan","year":"2002","journal-title":"J Rehabil Res Dev"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/hn.1999.v121.a101567","article-title":"Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Third place\u2014Resident Clinical Science Award 1998","volume":"121","author":"Ress","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AUD.0b013e3181e8b6a7","article-title":"Distortion-product otoacoustic emission test performance for ototoxicity monitoring","volume":"32","author":"Reavis","year":"2011","journal-title":"Ear Hear"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r24","unstructured":"Hallmark. RJ, Snyder. JM, Jusenius. K, Tamimi. HK. . Factors influencing ototoxicity in ovarian cancer patients treated with Cis-platinum based chemotherapy. Eur J Gynaec Oncol. 1992;13(1):35-44."},{"issue":"8","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r26","unstructured":"American Academy of Audiology. American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring [Internet]; Reston (VA); 2013. Available from: http:\/\/www.audiology.org\/resources\/documentlibrary\/Documents\/OtoMonGuidelines.pdf"},{"issue":"2","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r27","first-page":"105","article-title":"Reliability of evoked responses to high-frequency (8-14 kHz) tone bursts","volume":"2","author":"Fausti","year":"1991","journal-title":"J Am Acad Audiol"},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r28","first-page":"397","article-title":"Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses","volume":"3","author":"Fausti","year":"1992","journal-title":"J Am Acad Audiol"},{"issue":"2","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archotol.125.2.215","article-title":"High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions","volume":"125","author":"Arnold","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6 Pt 1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0194-5998(97)70232-8","article-title":"Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils","volume":"116","author":"Sie","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r31","unstructured":"Hodges AV, Lonsbury-Martin BL. Hearing management. San Diego (CA): Singular Press, 1998."},{"issue":"6","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r32","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1121\/1.428201","article-title":"Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. II. Fine structure for different shapes of cochlear hearing loss","volume":"106","author":"Mauermann","year":"1999","journal-title":"J Acoust Soc Am"},{"issue":"4","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r33","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1121\/1.1455024","article-title":"Sources of DPOAEs revealed by suppression experiments, inverse fast Fourier transforms, and SFOAEs in impaired ears","volume":"111","author":"Konrad-Martin","year":"2002","journal-title":"J Acoust Soc Am"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r34","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3109\/14992027.2011.635713","article-title":"Multivariate DPOAE metrics for identifying changes in hearing: Perspectives from ototoxicity monitoring","volume":"51","author":"Konrad-Martin","year":"2012","journal-title":"Int J Audiol"},{"issue":"3\u20134","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0531-5565(94)00052-5","article-title":"Central auditory aging: GABA changes in the inferior colliculus","volume":"30","author":"Caspary","year":"1995","journal-title":"Exp Gerontol"},{"issue":"3","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19970901)385:3<405::AID-CNE5>3.0.CO;2-7","article-title":"Glycine immunoreactivity and receptor binding in the cochlear nucleus of C57BL\/6J and CBA\/CaJ mice: Effects of cochlear impairment and aging","volume":"385","author":"Willott","year":"1997","journal-title":"J Comp Neurol"},{"issue":"1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuroscience.2009.01.079","article-title":"Age-related changes in glycine receptor subunit composition and binding in dorsal cochlear nucleus","volume":"160","author":"Wang","year":"2009","journal-title":"Neuroscience"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r38","unstructured":"National Institute on Deafness and other Communication Disorders. Quick statistics [Internet]; 2010 [cited 24 Aug 2013]. Available from: http:\/\/www.nidcd.nih.gov\/health\/statistics\/Pages\/quick.aspx"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r39","unstructured":"Dille MF, McMillan GP, Reavis KM, Jacobs PG, Fausti SA, Konrad-Martin D. Pre-treatment ototoxicity risk assessment for Veterans prescribed cisplatin. Association for VA Hematology\/Oncology; 2012 Oct 19\u201321; Omaha, NE."},{"issue":"5","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/AUD.0b013e31828a21b3","article-title":"The statistical basis for serial monitoring in audiology","volume":"34","author":"McMillan","year":"2013","journal-title":"Ear Hear"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r41","unstructured":"Konrad-Martin D, Jacobs PG, McMillan GP, Reavis KM, Dille MF. Usefulness of source knowledge for detecting ototoxicity using DPOAEs. Midwinter Meeting of the Association for Research in Otolaryngology; 2012 Feb; San Diego, CA."},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r42","unstructured":"Reavis K, McMillan G, Konrad-Martin D, Jacobs P, Dille MF. Dose-related effect of cisplatin on distortion product otoacoustic emissions in Veterans. Midwinter Meeting of the Association for Research in Otolaryngology; 2012 Feb; San Diego, CA."},{"issue":"2","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1682\/JRRD.2003.03.0159","article-title":"Guide to conducting tinnitus retraining therapy initial and follow-up interviews","volume":"40","author":"Henry","year":"2003","journal-title":"J Rehabil Res Dev"},{"issue":"55","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4103\/1463-1741.90322","article-title":"Ambient noise levels in the chemotherapy clinic","volume":"13","author":"Gladd","year":"2011","journal-title":"Noise Health"},{"issue":"3","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r45","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1682\/JRRD.2004.06.0093","article-title":"Evaluation of insert earphones for high-frequency bedside ototoxicity monitoring","volume":"42","author":"Gordon","year":"2005","journal-title":"J Rehabil Res Dev"},{"key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r46","unstructured":"American National Standards Institute. ANSI S3\u20131\u20131996. In: American National Standards Specification for Audiometers. New York (NY): ANSI; 1999."},{"issue":"1","key":"key-10.1682\/JRRD.2013.04.0092-201404211424-r47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/00206099909072998","article-title":"The maximum permissible ambient noise and frequency-specific averaging time on the measurement of distortion product otoacoustic emissions","volume":"38","author":"Lee","year":"1999","journal-title":"Audiology"}],"container-title":["Journal of Rehabilitation Research and Development"],"original-title":[],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:02:44Z","timestamp":1781089364000},"score":1,"resource":{"primary":{"URL":"https:\/\/web.archive.org\/web\/20220312221303\/https:\/\/www.rehab.research.va.gov\/jour\/2014\/511\/pdf\/JRRD-2013-04-0092.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1682\/jrrd.2013.04.0092","relation":{},"ISSN":["0748-7711","1938-1352"],"issn-type":[{"value":"0748-7711","type":"print"},{"value":"1938-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}